Trade Baxter International - BAX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.14 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.025457% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003235% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Baxter International Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 40.27 |
Open* | 39.93 |
1-Year Change* | -47.5% |
Day's Range* | 39.88 - 40.86 |
52 wk Range | 37.35-76.51 |
Average Volume (10 days) | 4.34M |
Average Volume (3 months) | 122.07M |
Market Cap | 20.40B |
P/E Ratio | -100.00K |
Shares Outstanding | 505.85M |
Revenue | 15.06B |
EPS | -4.89 |
Dividend (Yield %) | 2.87627 |
Beta | 0.56 |
Next Earnings Date | Jul 26, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
May 31, 2023 | 40.64 | 0.73 | 1.83% | 39.91 | 40.86 | 39.72 |
May 30, 2023 | 40.27 | -0.38 | -0.93% | 40.65 | 41.02 | 40.16 |
May 26, 2023 | 41.22 | -0.10 | -0.24% | 41.32 | 41.54 | 40.80 |
May 25, 2023 | 41.28 | -0.07 | -0.17% | 41.35 | 41.49 | 40.76 |
May 24, 2023 | 42.07 | 0.05 | 0.12% | 42.02 | 42.34 | 41.71 |
May 23, 2023 | 42.44 | 0.12 | 0.28% | 42.32 | 43.18 | 42.10 |
May 22, 2023 | 42.52 | -0.21 | -0.49% | 42.73 | 43.07 | 42.37 |
May 19, 2023 | 42.92 | -0.03 | -0.07% | 42.95 | 43.31 | 42.64 |
May 18, 2023 | 42.97 | 0.47 | 1.11% | 42.50 | 43.02 | 42.30 |
May 17, 2023 | 42.72 | 0.06 | 0.14% | 42.66 | 43.16 | 42.42 |
May 16, 2023 | 42.95 | 0.59 | 1.39% | 42.36 | 43.62 | 42.28 |
May 15, 2023 | 42.63 | 0.19 | 0.45% | 42.44 | 43.08 | 42.13 |
May 12, 2023 | 42.41 | -0.69 | -1.60% | 43.10 | 43.45 | 42.19 |
May 11, 2023 | 43.30 | -0.25 | -0.57% | 43.55 | 43.78 | 42.97 |
May 10, 2023 | 43.75 | 0.69 | 1.60% | 43.06 | 44.12 | 42.85 |
May 9, 2023 | 43.04 | -1.81 | -4.04% | 44.85 | 44.85 | 42.31 |
May 8, 2023 | 45.56 | -0.69 | -1.49% | 46.25 | 47.09 | 44.75 |
May 5, 2023 | 46.00 | 0.55 | 1.21% | 45.45 | 46.11 | 45.15 |
May 4, 2023 | 45.24 | -0.75 | -1.63% | 45.99 | 46.30 | 45.16 |
May 3, 2023 | 46.43 | -0.55 | -1.17% | 46.98 | 47.48 | 46.41 |
Baxter International Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, June 1, 2023 | ||
Time (UTC) 12:00 | Country US
| Event Baxter International Inc Baxter International IncForecast -Previous - |
Time (UTC) 12:00 | Country US
| Event Baxter International Inc Baxter International IncForecast -Previous - |
Thursday, June 8, 2023 | ||
Time (UTC) 14:00 | Country US
| Event Baxter International Inc at Jefferies Healthcare Conference Baxter International Inc at Jefferies Healthcare ConferenceForecast -Previous - |
Wednesday, July 26, 2023 | ||
Time (UTC) 13:30 | Country US
| Event Q2 2023 Baxter International Inc Earnings Release Q2 2023 Baxter International Inc Earnings ReleaseForecast -Previous - |
Wednesday, October 25, 2023 | ||
Time (UTC) 12:30 | Country US
| Event Q3 2023 Baxter International Inc Earnings Release Q3 2023 Baxter International Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 15113 | 12784 | 11673 | 11362 | 11099 |
Revenue | 15113 | 12784 | 11673 | 11362 | 11099 |
Cost of Revenue, Total | 9690 | 7626 | 7038 | 6541 | 6305 |
Gross Profit | 5423 | 5158 | 4635 | 4821 | 4794 |
Total Operating Expense | 17207 | 11129 | 10213 | 10345 | 9492 |
Selling/General/Admin. Expenses, Total | 3609 | 2619 | 2357 | 2397 | 2387 |
Research & Development | 602 | 529 | 496 | 508 | 599 |
Unusual Expense (Income) | 3306 | 355 | 322 | 899 | 210 |
Other Operating Expenses, Total | -9 | ||||
Operating Income | -2094 | 1655 | 1460 | 1017 | 1607 |
Interest Income (Expense), Net Non-Operating | -400 | -170 | -170 | -124 | -28 |
Other, Net | 141 | -8 | 2 | 77 | 38 |
Net Income Before Taxes | -2353 | 1477 | 1292 | 970 | 1617 |
Net Income After Taxes | -2421 | 1295 | 1110 | 817 | 1345 |
Net Income Before Extra. Items | -2433 | 1284 | 1102 | 807 | 1345 |
Total Extraordinary Items | 0 | 0 | 194 | 201 | |
Net Income | -2433 | 1284 | 1102 | 1001 | 1546 |
Income Available to Common Excl. Extra. Items | -2433 | 1284 | 1102 | 807 | 1345 |
Income Available to Common Incl. Extra. Items | -2433 | 1284 | 1102 | 1001 | 1546 |
Diluted Net Income | -2433 | 1284 | 1102 | 1001 | 1546 |
Diluted Weighted Average Shares | 504 | 508 | 517 | 519 | 546 |
Diluted EPS Excluding Extraordinary Items | -4.82738 | 2.52756 | 2.13153 | 1.55491 | 2.46337 |
Dividends per Share - Common Stock Primary Issue | 1.15 | 1.085 | 0.955 | 0.85 | 0.73 |
Diluted Normalized EPS | 2.10317 | 3.0315 | 2.60928 | 2.84008 | 2.4359 |
Minority Interest | -12 | -11 | -8 | -10 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 3649 | 3887 | 3773 | 3746 | 3707 |
Revenue | 3649 | 3887 | 3773 | 3746 | 3707 |
Cost of Revenue, Total | 2300 | 2418 | 2626 | 2289 | 2357 |
Gross Profit | 1349 | 1469 | 1147 | 1457 | 1350 |
Total Operating Expense | 3463 | 3696 | 6572 | 3395 | 3544 |
Selling/General/Admin. Expenses, Total | 774 | 986 | 782 | 817 | 790 |
Research & Development | 157 | 153 | 148 | 148 | 149 |
Unusual Expense (Income) | 180 | 139 | 2958 | 60 | 153 |
Operating Income | 186 | 191 | -2799 | 351 | 163 |
Interest Income (Expense), Net Non-Operating | -126 | -153 | -172 | -66 | -96 |
Other, Net | 10 | 186 | 5 | 10 | 27 |
Net Income Before Taxes | 70 | 224 | -2966 | 295 | 94 |
Net Income After Taxes | 45 | 185 | -2934 | 255 | 73 |
Minority Interest | -1 | -4 | -3 | -3 | -2 |
Net Income Before Extra. Items | 44 | 181 | -2937 | 252 | 71 |
Net Income | 44 | 181 | -2937 | 252 | 71 |
Income Available to Common Excl. Extra. Items | 44 | 181 | -2937 | 252 | 71 |
Income Available to Common Incl. Extra. Items | 44 | 181 | -2937 | 252 | 71 |
Diluted Net Income | 44 | 181 | -2937 | 252 | 71 |
Diluted Weighted Average Shares | 507 | 507 | 504 | 508 | 509 |
Diluted EPS Excluding Extraordinary Items | 0.08679 | 0.357 | -5.82738 | 0.49606 | 0.13949 |
Dividends per Share - Common Stock Primary Issue | 0.29 | 0.29 | 0.29 | 0.29 | 0.28 |
Diluted Normalized EPS | 0.41026 | 0.50296 | 0.43849 | 0.5315 | 0.62672 |
Depreciation / Amortization | 52 | 58 | 81 | 95 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 8011 | 8872 | 8411 | 7503 | 5959 |
Cash and Short Term Investments | 1718 | 2951 | 3730 | 3335 | 1838 |
Cash & Equivalents | 1718 | 2951 | 3730 | 3335 | 1838 |
Short Term Investments | |||||
Total Receivables, Net | 2752 | 2713 | 2077 | 1896 | 1840 |
Accounts Receivable - Trade, Net | 2752 | 2713 | 2077 | 1896 | 1840 |
Total Inventory | 2718 | 2453 | 1916 | 1653 | 1667 |
Prepaid Expenses | 424 | 365 | 346 | 230 | 210 |
Other Current Assets, Total | 399 | 390 | 342 | 389 | 404 |
Total Assets | 28287 | 33521 | 20019 | 18193 | 15720 |
Property/Plant/Equipment, Total - Net | 5529 | 5808 | 5325 | 5120 | 4530 |
Property/Plant/Equipment, Total - Gross | 11971 | 12358 | 11874 | 11268 | 10333 |
Accumulated Depreciation, Total | -6442 | -6550 | -6549 | -6148 | -5803 |
Goodwill, Net | 6843 | 9836 | 3217 | 3030 | 3002 |
Intangibles, Net | 6793 | 7792 | 1671 | 1471 | 1410 |
Other Long Term Assets, Total | 653 | 835 | 1038 | 762 | 599 |
Total Current Liabilities | 4745 | 4236 | 3333 | 3230 | 2814 |
Accounts Payable | 1139 | 1246 | 1043 | 892 | 998 |
Payable/Accrued | 571 | 638 | 704 | ||
Accrued Expenses | 1801 | 2087 | 1053 | 961 | 900 |
Notes Payable/Short Term Debt | 299 | 301 | 0 | 226 | 2 |
Current Port. of LT Debt/Capital Leases | 1105 | 210 | 406 | 315 | 2 |
Other Current Liabilities, Total | 401 | 392 | 260 | 198 | 208 |
Total Liabilities | 22454 | 24444 | 11330 | 10311 | 7876 |
Total Long Term Debt | 15232 | 17149 | 5786 | 4809 | 3481 |
Long Term Debt | 15170 | 17081 | 5722 | 4755 | 3481 |
Deferred Income Tax | 698 | 962 | 143 | 192 | 215 |
Minority Interest | 62 | 44 | 37 | 30 | 22 |
Other Liabilities, Total | 1717 | 2053 | 2031 | 2050 | 1344 |
Total Equity | 5833 | 9077 | 8689 | 7882 | 7844 |
Common Stock | 683 | 683 | 683 | 683 | 683 |
Additional Paid-In Capital | 6322 | 6197 | 6043 | 5955 | 5898 |
Retained Earnings (Accumulated Deficit) | 14050 | 17065 | 16328 | 15718 | 15075 |
Treasury Stock - Common | -11389 | -11488 | -11051 | -10764 | -9989 |
Other Equity, Total | -3833 | -3380 | -3314 | -3710 | -3823 |
Total Liabilities & Shareholders’ Equity | 28287 | 33521 | 20019 | 18193 | 15720 |
Total Common Shares Outstanding | 504.432 | 501.615 | 504.915 | 506.155 | 512.999 |
Note Receivable - Long Term | 211 | 224 | 222 | 231 | 176 |
Long Term Investments | 247 | 154 | 135 | 76 | 44 |
Capital Lease Obligations | 62 | 68 | 64 | 54 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 8099 | 8011 | 7810 | 7882 | 8173 |
Cash and Short Term Investments | 1673 | 1718 | 1601 | 1852 | 2294 |
Cash & Equivalents | 1673 | 1718 | 1601 | 1852 | 2294 |
Total Receivables, Net | 2639 | 2659 | 2555 | 2473 | 2471 |
Accounts Receivable - Trade, Net | 2639 | 2659 | 2555 | 2473 | 2471 |
Total Inventory | 2922 | 2718 | 2675 | 2663 | 2548 |
Prepaid Expenses | 861 | 912 | 976 | 890 | 855 |
Other Current Assets, Total | 4 | 4 | 3 | 4 | 5 |
Total Assets | 28291 | 28287 | 27965 | 31831 | 32716 |
Property/Plant/Equipment, Total - Net | 5554 | 5529 | 5345 | 5542 | 5723 |
Property/Plant/Equipment, Total - Gross | 11622 | 11421 | 11084 | 11504 | 11757 |
Accumulated Depreciation, Total | -6622 | -6442 | -6285 | -6528 | -6643 |
Goodwill, Net | 6868 | 6843 | 6639 | 9644 | 9816 |
Intangibles, Net | 6640 | 6793 | 6927 | 7459 | 7693 |
Other Long Term Assets, Total | 1011 | 1111 | 1244 | 1304 | 1311 |
Total Current Liabilities | 4760 | 4745 | 3708 | 3916 | 3890 |
Accounts Payable | 1290 | 1139 | 1234 | 1282 | 1223 |
Accrued Expenses | 2157 | 2202 | 2195 | 2226 | 2258 |
Notes Payable/Short Term Debt | 50 | 299 | 275 | 200 | 200 |
Current Port. of LT Debt/Capital Leases | 1103 | 1105 | 4 | 208 | 209 |
Total Liabilities | 22412 | 22454 | 22430 | 22972 | 23641 |
Total Long Term Debt | 15278 | 15232 | 16153 | 16278 | 16765 |
Long Term Debt | 15278 | 15232 | 16153 | 16278 | 16765 |
Minority Interest | 62 | 62 | 44 | 44 | 44 |
Other Liabilities, Total | 2312 | 2415 | 2525 | 2734 | 2942 |
Total Equity | 5879 | 5833 | 5535 | 8859 | 9075 |
Common Stock | 683 | 683 | 683 | 683 | 683 |
Additional Paid-In Capital | 6312 | 6322 | 6297 | 6253 | 6207 |
Retained Earnings (Accumulated Deficit) | 13947 | 14050 | 14015 | 17099 | 16994 |
Treasury Stock - Common | -11324 | -11389 | -11406 | -11409 | -11422 |
Other Equity, Total | -3739 | -3833 | -4054 | -3767 | -3387 |
Total Liabilities & Shareholders’ Equity | 28291 | 28287 | 27965 | 31831 | 32716 |
Total Common Shares Outstanding | 505.836 | 504.432 | 504.044 | 503.807 | 503.437 |
Note Receivable - Long Term | 119 | ||||
Other Current Liabilities, Total | 160 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -2421 | 1295 | 1110 | 1011 | 1546 |
Cash From Operating Activities | 1211 | 2222 | 1868 | 2104 | 2017 |
Cash From Operating Activities | 1403 | 890 | 823 | 789 | 771 |
Deferred Taxes | -225 | -146 | -88 | -310 | -263 |
Non-Cash Items | 3477 | 344 | 295 | 1039 | 211 |
Cash Taxes Paid | 330 | 282 | 249 | 294 | 301 |
Cash Interest Paid | 355 | 145 | 137 | 103 | 94 |
Changes in Working Capital | -1023 | -161 | -272 | -425 | -248 |
Cash From Investing Activities | -931 | -11200 | -1179 | -1100 | -916 |
Capital Expenditures | -679 | -743 | -709 | -696 | -659 |
Other Investing Cash Flow Items, Total | -252 | -10457 | -470 | -404 | -257 |
Cash From Financing Activities | -1438 | 8245 | -345 | 498 | -2603 |
Financing Cash Flow Items | -61 | -138 | -52 | -48 | -33 |
Total Cash Dividends Paid | -573 | -530 | -473 | -423 | -376 |
Issuance (Retirement) of Stock, Net | 95 | -413 | -298 | -914 | -2194 |
Issuance (Retirement) of Debt, Net | -899 | 9326 | 478 | 1883 | 0 |
Foreign Exchange Effects | -76 | -47 | 57 | -5 | -63 |
Net Change in Cash | -1234 | -780 | 401 | 1497 | -1565 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 45 | -2421 | -2606 | 328 | 73 |
Cash From Operating Activities | 479 | 1211 | 772 | 482 | 208 |
Cash From Operating Activities | 319 | 1403 | 1069 | 735 | 380 |
Deferred Taxes | -50 | -225 | -174 | -87 | -55 |
Non-Cash Items | 35 | 3477 | 3365 | 64 | 34 |
Changes in Working Capital | 130 | -1023 | -882 | -558 | -224 |
Cash From Investing Activities | -170 | -931 | -675 | -491 | -304 |
Capital Expenditures | -172 | -679 | -479 | -311 | -140 |
Other Investing Cash Flow Items, Total | 2 | -252 | -196 | -180 | -164 |
Cash From Financing Activities | -372 | -1438 | -1319 | -1017 | -548 |
Financing Cash Flow Items | -10 | -61 | -51 | -30 | -25 |
Total Cash Dividends Paid | -146 | -573 | -427 | -281 | -140 |
Issuance (Retirement) of Stock, Net | 36 | 95 | 82 | 88 | 66 |
Issuance (Retirement) of Debt, Net | -252 | -899 | -923 | -794 | -449 |
Foreign Exchange Effects | 18 | -76 | -130 | -74 | -13 |
Net Change in Cash | -45 | -1234 | -1352 | -1100 | -657 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.9709 | 60554683 | 11083859 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4583 | 27610959 | 452915 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2077 | 21284408 | -212345 | 2023-03-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 3.5746 | 18082159 | 8186853 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.9578 | 9903377 | 2132589 | 2023-03-31 | HIGH |
Macquarie Investment Management | Investment Advisor | 1.8235 | 9224199 | 1449983 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7735 | 8971166 | 170213 | 2023-03-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 1.6831 | 8513989 | 8512295 | 2023-03-31 | LOW |
Morgan Stanley Investment Management Ltd. (UK) | Investment Advisor | 1.5794 | 7989246 | -17797773 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.4706 | 7439184 | 1748181 | 2022-12-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 1.4243 | 7204767 | 114267 | 2023-03-31 | MED |
State Farm Insurance Companies | Insurance Company | 1.3548 | 6853390 | 0 | 2023-03-31 | LOW |
Generation Investment Management LLP | Investment Advisor/Hedge Fund | 1.3165 | 6659564 | -4222750 | 2023-03-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.1821 | 5979786 | 3271267 | 2023-03-31 | HIGH |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 1.1403 | 5768387 | 1338203 | 2023-03-31 | LOW |
Millennium Management LLC | Hedge Fund | 1.058 | 5351665 | 2242199 | 2023-03-31 | HIGH |
BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 1.017 | 5144535 | 2302815 | 2023-03-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.0063 | 5090367 | -97615 | 2023-03-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9582 | 4847098 | 636287 | 2023-03-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.9343 | 4726213 | 3483763 | 2023-03-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group530K+
Traders
87K+
Active clients monthly
$46M+
Monthly investing volume
$31M+
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Baxter Company profile
About Baxter International Inc
Baxter International Inc. through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Baxter International Inc revenues increased 10% to $12.78B. Net income increased 17% to $1.28B. Revenues reflect Americas segment increase of 10% to $6.67B, APAC segment increase of 13% to $2.79B. Net income benefited from Americas segment income increase of 17% to $2.61B, APAC segment income increase of 5% to $623M. Dividend per share increased from $0.96 to $1.09.
Equity composition
Common Stock $1 Par, 03/11, 2B auth., 683,494,944 issd., Less 112,110,796 Shs. in Treas. @$6.1M. Insiders control approx. 0.15%. PO 6/86, 1.85M shares @$18.75 by Goldman Sachs. *FY'98-'01 are restated for disc. ops. 5/01, 2-for-1 stock split. *5/02, Co acquired Fusion Medical Technologies @ 0.1763 (2,507,881 shs. issd.).
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Df2-1W
One Baxter Pkwy
DEERFIELD
ILLINOIS 60015
US
Income Statement
- Annual
- Quarterly
News

Nvidia’s 5-year stock forecast: Will the chipmaker remain at record highs?
Nvidia has been the winner of the AI race, being the first chip-maker to hit a $1tn market cap. Will the growth continue?
07:46, 31 May 2023
Google stock forecast 2023-2025
What is the outlook for the tech giant, following a tumultuous 2022?
18:02, 30 May 2023
USD forecast: DXY slides in risk-off market sentiment
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
16:10, 24 May 2023
Oil price forecast: Will WTI and Brent regain momentum in 2023?
Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.
11:38, 22 May 2023
Weekly Roundup: Tech stocks lead the way
US stocks push higher as risk appetite surges despite the uncertainty
13:39, 19 May 2023
USD/JPY continues to build higher towards 138
USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher
11:50, 17 May 2023
Gold price predictions for next 5 years: Will gold continue rising?
The yellow metal reached near record-highs, yet will it maintain the momentum and for how long?
07:50, 17 May 2023People also watch
Still looking for a broker you can trust?
Join the 530.000+ traders worldwide that chose to trade with Capital.com